Categories
HIV

Mylan signs HIV test commercialization deal with Atomo Diagnostics

Firstly, i would like to congratulate both Atomo Diagnostics and Mylan for forming these powerful alliance to help the lower income people to have access to these HIV test kit. And another congratulations to Atomo Diagnostics for secured the European CE-Mark in October last year. The test is a qualitative immunoassay designed to detect antibodies […]

Firstly, i would like to congratulate both Atomo Diagnostics and Mylan for forming these powerful alliance to help the lower income people to have access to these HIV test kit.

And another congratulations to Atomo Diagnostics for secured the European CE-Mark in October last year. The test is a qualitative immunoassay designed to detect antibodies to HIV type 1 and type 2 in human whole blood.

For those who do not know, Atomo HIV Test kit is indeed “very canggih” unique i would say, because personally i like Atomo HIV test kit design, thanks to the Founder and CEO John Kelly.

Mylan received exclusive rights for commercialisation of in-vitro HIV rapid diagnostic tests in more than 100 countries across Africa, Asia, the Middle East, the Commonwealth of Independent States (CIS) and Latin America.

HIV testing rates have improved but expanding access to the tests is still a challenge in certain countries.

Mylan noted that offering point-of-care self-tests in community-based settings can increase the proportion of people aware of their HIV status, in turn enabling treatment or prevention.

Through the new partnership, the companies will provide all-in-one test devices, which are designed to deliver better functionality and are easy to use compared to existing multi-component rapid diagnostic tests.

Mylan CEO Heather Bresch said: “Our partnership with Atomo to supply HIV rapid diagnostic tests for self-testing is an important step in our collective goal of preventing HIV infections and expanding treatment.”

HIV Self Test by Atomo Diagnostics secured the European CE-Mark in October last year. The test is a qualitative immunoassay designed to detect antibodies to HIV type 1 and type 2 in human whole blood.

Atomo Diagnostics founder and CEO John Kelly said: “This strategic partnership will mean that the products designed by Atomo can be introduced to more than 100 countries, so that millions of people will have access to award-winning rapid tests.

“We believe that Mylan is the ideal partner to ensure that our HIV self-test products have maximum impact in the fight against HIV/AIDS.”

Mylan intends to globally launch the Mylan HIV Self-Test early next year.

Let me know your comments about Atomo HIV Test kit.

 

Knowledge of the Day 

“Global pharmaceutical company Mylan launch two new HIV treatments, Symfi Lo™ and Cimduo™, which were approved in February by the U.S. Food and Drug Administration (FDA). ”